Data / Form D filings / S1P Therapeutics Inc.
S1P Therapeutics Inc.: Form D filing
S1P Therapeutics Inc., a pharmaceuticals company in Blacksburg, VA, filed a Form D with the SEC in 2023. The latest, on June 9, 2023, reports $2 million sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 501 WILDFLOWER LANE, Blacksburg, VA, 24060
- Phone
- (703) 679-2626
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1980623
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2023 | New notice | $3,000,000 | $2,016,999 | $983,001 | 1 | May 31, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Lynch | Executive Officer, Director | |
| Webster Santos | Executive Officer, Director | |
| Ronald Sayco | Executive Officer, Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Jun 5, 2023 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what S1P Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.